GHRS

NASD GH Research Plc
Oct 22, 2026 · 7:06 AM ET LAST TRADE Market Closed

$19.00 ↑ +0.09 (+0.48%) Trading Up from the previous close of $18.91

YTD change
+49.61%
vs 20-day SMA
-10.10%
vs 200-day SMA
-11.24%

Price ranges

Previous day
$18.81 $19.81
open $19.22 close $18.91
-$0.31 (-1.61%)
Today
$0.00 $0.00
$19.00
Past week
$18.02 $19.81
from $18.56 now $19.00
+$0.44 (+2.37%)
Past month
$18.02 $26.10
from $25.96 now $19.00
-$6.96 (-26.81%)
This year
$12.70 $31.44
from $12.70 now $19.00
+$6.30 (+49.61%)

Price & Performance

-0.04 (-0.21%) / 6M

$17.15$21.98$26.81$31.64Apr 22Jul 23Oct 21

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 39.6% away from all-time highs of $31.44
  • GHRS is up 50% since the beginning of the year
  • GHRS is up 49% over the past 12 months
  • GHRS is down 27% over the past 1 month
  • 4% of all GHRS investors are betting against GHRS

GHRS reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +48.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.23
Earnings momentum +26.3% Quarterly EPS growth
Quarterly change +26.3%

Valuation

P/E ratio N/A
Enterprise value $895.9M
Beta 1.87

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$362.6M
Debt$360.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.3B

GH Research Plc is a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients with psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $438.34 -0.14%
MRNA Moderna, Inc. $245.81 +1.54%
RVMD Revolution Medicines, Inc. $194.28 -1.15%
ROIV Roivant Sciences Ltd. $36.80 +5.38%
BNTX BioNTech SE Sponsored ADR $91.29 +0.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.